Eric Lefkofsky created Tempus when he hadn’t entered a science class since college. The company is attempting to merge artificial intelligence ad healthcare. Eric was at the age of 49 when he launched five companies that totaled approximately $250 million each. All of the companies promise to transform the health industry by using entered data. Tempus is designed to be use by doctors utilizing the information stored in order to personalize cancer treatments. Eventually, making them more effective.
An example is a doctor treating a patient with lung cancer, but he may send tumor biopsy to Tempus for sequencing. Tempus will take that sample and identify the mutation in the gene for epidermal growth. This is what causes the cells to grow and divide on a non-normal level. Then the doctor will prescribe a specific therapy that performs better than chemotherapy. The company consists of 700-employee and has raised $520 million.
Eric’s company, Tempus, also license a library of data that pushes out information to drug companies, providers, and researchers. Lefkofsky attended the University of Michigan, where he studied history, but had a sudden urge to be an entrepreneur. Andrew Mason was one of Eric’s first hires and he pitched an idea for a business venture to Lefkofsky. In which, Lefkpfsky decided to invest $1 million. This company that Andrew spoke of became the leading discount sight named Groupon.
In 2014, Lefkofsky’s wife, Liz, was diagnosed with breast cancer.
After this discovery. Eric Lefkofsky started another startup called Concerto Health AI. The new health startup company was supported by Romesh Wadhwani. The company is similar in build to Tempus. Whereas the doctors at UC Davis are now involve with Tempus, they are one of the few that have only sent about 100 samples to Tempus. This is considerably fewer samples sent than what they have shipped out to another genetic sample company named Foundation.